Abstract: During surgery, debris being cleared from the target anatomy may inadvertently inhibit fluid communication between a suction instrument and a suction source. Therefore, it may be desirable to facilitate access to interior portions of the suction instrument and control of the amount of suction being provided through the suction instrument. The suction instrument can include an elongate cannula with a distal portion configured to be positioned within or adjacent to an anatomical passageway of a patient. The elongate cannula can define a suction lumen that can provide suction at the distal portion. A handle assembly can be associated with the elongate cannula and include a deformable grasping body defining a fluid communication chamber that can provide suction to the suction lumen. The deformable grasping body can elastically deform between relaxed and compressed states to alter the fluid communication between the fluid communication chamber and the suction lumen.

Abstract: Catheter shafts (such as guide catheter or dilation catheter shafts) disclosed herein can include a rigid proximal portion, a deflectable distal portion located distally from the proximal portion, and a pull wire extending from the deflectable distal portion along the proximal portion. The pull wire can drive the deflectable distal portion between a straight configuration and a bent configuration, which makes the catheter system adaptable for use with both pediatric and adult patients. Specifically, because the pull wire facilitates changing a bend angle of the deflectable distal portion of the catheter shaft, the catheter can fit in a wide variety of differently sized nasal cavities and Eustachian Tubes. Optionally, a visualizing distal tip can be positioned distally from the deflectable distal portion of the catheter shaft and include a distally facing camera that can be used to confirm that the deflectable distal portion is properly positioned in the patient.

Abstract: The present application discloses an implant with a shaft defining a longitudinal axis and an extendable sleeve including a proximal end and a distal end. The extendable sleeve is positioned around the shaft and is configured to bear radially outward against a Eustachian tube of a patient. The distal end of the extendable sleeve is configured to translate with the shaft. The proximal end of the sleeve is configured to translate relative to the shaft. The present application also discloses an apparatus that includes the implant and an instrument that facilitates the implant between an insertion position and a released position. Finally, the present application discloses methods for use of the implant and the apparatus.

Abstract: An apparatus for use with an instrument includes a hub, a shaft assembly, and a navigation sensor. The hub is configured to engage a portion of the instrument, in only a predetermined angular orientation with respect to an axis of the instrument. The shaft assembly extends from the hub and defines a hollow interior and an open distal end. The hollow interior is configured to receive a tubular portion of the instrument. The navigation sensor can be disposed proximate the open distal end of the shaft assembly. The navigation sensor can be configured to generate a signal indicating a portion of at least a portion of the shaft assembly in three-dimensional space.

Abstract: The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, arid antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.

Abstract: The invention provides human signal peptide-containing proteins (HSPP) and polynucleotides which identify and encode HSPP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HSPP.

Abstract: The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.

Abstract: The invention provides human signal peptide-containing proteins (HSPP) and polynucleotides which identify and encode HSPP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HSPP.

Abstract: Various embodiments of the invention provide human kinases and phosphatases (KPP) polypeptides and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.

Abstract: The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.

Abstract: The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.

Abstract: The invention provides human signal peptide-containing proteins (HSPP) and polynucleotides which identify and encode HSPP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HSPP.

Abstract: The invention provides human signal peptide-containing proteins (HSPP) and polynucleotides which identify and encode HSPP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HSPP.

Abstract: The invention provides human signal peptide-containing proteins (HSPP) and polynucleotides which identify and encode HSPP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HSPP.

Abstract: The invention provides human signal peptide-containing proteins (HSPP) and polynucleotides which identify and encode HSPP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HSPP.

Abstract: A processing method and apparatus uses at least one electric field applicator (34) biased to produce a spatial-temporal electric field to affect a processing medium (26), suspended nano-objects (28) or the substrate (30) in processing, interacting with the dipole properties of the medium (26) or particles to construct structure on the substrate (30). The apparatus may include a magnetic field, an acoustic field, an optical force, or other generation device. The processing may affect selective localized layers on the substrate (30) or may control orientation of particles in the layers, control movement of dielectrophoretic particles or media, or cause suspended particles of different properties to follow different paths in the processing medium (26). Depositing or modifying a layer on the substrate (30) may be carried out.

Abstract: A multi-patterning method of manufacturing a patterned wafer provides test structures designed to enhance overlay error measurement sensitivity for monitoring and process control. One or more patterns are overlaid on a first pattern, each of a given pitch, with the elements interleaved. Test structure is formed with elements of the overlaid patterns spaced away from respective mid-positions more closely toward elements of the first pattern. In some embodiments, test structure elements of the second pattern are overlaid midway between mid-positions of elements of the first pattern and measured by scatterometry. In other embodiments, test structure elements of the second pattern are overlaid at a slightly different pitch than the elements of the first pattern and measured by reflectivity. Measurements are compared with library measurements to identify the error, which may be fed back to control the patterning process. The multi-patterning may be formed by LELE, LLE, LFLE, or other methods.

Abstract: The invention provides human transmembrane proteins (HTMPN) and polynucleotides which identify and encode HTMPN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HTMPN.

Abstract: The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.

Abstract: Various embodiments of the invention provide human kinases and phosphatases (KPP) polypeptides and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.